Rizatriptan
Rizatriptan (Maxalt) is a triptan medicine used to treat migraine attacks as they happen. This listing includes Maxalt and Rizact tablets in 5 mg and 10 mg strengths.
Key points
- Acute treatment: Rizatriptan does not prevent future migraine attacks.
- Vascular conditions: Rizatriptan is not suitable for people with several ischaemic or vascular conditions.
- Recent migraine medicines: Another triptan or an ergot medicine used recently is an important suitability check.
Brands and forms in this catalogue
Maxalt and Rizact are both listed as rizatriptan tablets in 5 mg and 10 mg strengths. Maxalt is the originator brand, while Rizact is listed as a separate Cipla Ltd line. These tablet options sit within Neurology.

